OTC Pharmaceuticals - Germany

Germany

Revenue in the OTC Pharmaceuticals market amounts to US$10.29bn in 2024. The market is expected to grow annually by 2.79% (CAGR 2024-2029).
The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$4.35bn in 2024.
In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
In relation to total population figures, per person revenues of US$123.60 are generated in 2024.
In the OTC Pharmaceuticals market, 14.4% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Pharmaceuticals market in Germany is experiencing steady growth and development, driven by various factors such as customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Germany play a significant role in shaping the OTC Pharmaceuticals market.

German consumers value convenience and self-care, which has led to an increased demand for over-the-counter medications. Many Germans prefer to treat minor ailments themselves rather than visit a doctor, and OTC medications provide them with a convenient and accessible option. Additionally, the aging population in Germany has contributed to the growth of the OTC Pharmaceuticals market, as older individuals often require medications for chronic conditions that can be managed with over-the-counter products.

Trends in the market also contribute to the development of the OTC Pharmaceuticals market in Germany. One notable trend is the growing popularity of natural and herbal remedies. German consumers are increasingly seeking out alternative and holistic approaches to healthcare, leading to a rise in demand for OTC products that are perceived as more natural and less chemically-based.

This trend has prompted pharmaceutical companies to develop and market a wider range of natural and herbal OTC products to cater to this demand. Local special circumstances in Germany further impact the OTC Pharmaceuticals market. The German healthcare system places a strong emphasis on self-care and prevention, which aligns with the use of over-the-counter medications.

The availability and accessibility of OTC products in pharmacies and supermarkets also contribute to the market's growth. Additionally, Germany has a well-established regulatory framework for OTC medications, ensuring their safety and quality. This regulatory environment instills confidence in consumers and encourages them to purchase OTC products.

Underlying macroeconomic factors also play a role in the development of the OTC Pharmaceuticals market in Germany. The country's strong economy and high disposable income levels enable consumers to afford OTC medications. Furthermore, the healthcare system in Germany provides limited coverage for certain prescription medications, making OTC alternatives more attractive from a cost perspective.

This combination of economic factors and healthcare coverage contributes to the sustained growth of the OTC Pharmaceuticals market. In conclusion, the OTC Pharmaceuticals market in Germany is experiencing growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for convenience and self-care, the popularity of natural and herbal remedies, the emphasis on self-care in the healthcare system, and the country's strong economy all contribute to the market's positive trajectory.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.